A common heart and blood pressure drug also blocks calcium channels in the gut and nerves

A common heart and blood pressure drug also blocks calcium channels in the gut and nerves
Image: Intellect (generated)

In short: Verapamil is a calcium channel blocker used for blood pressure, chest pain and irregular heartbeats. Its action goes beyond the heart: it relaxes blood vessels, slows conduction through the heart's electrical node and even affects cells used to study cancer. Understanding how one molecule acts across the body shows how medicine works.

Verapamil belongs to the non-dihydropyridine family of calcium channel blockers. Its basic mechanism is to block voltage-dependent calcium channels. Calcium channels are concentrated in the sinoatrial and atrioventricular nodes of the heart, so the drug can slow impulse conduction through the AV node. In cardiac pharmacology this places it among class-IV antiarrhythmic agents, and it is used to control ventricular rate in supraventricular tachycardia and to prevent paroxysmal supraventricular tachycardia.

Calcium channels also sit in the smooth muscle that lines blood vessels. Relaxing that muscle dilates the vessels. In angina, the pain comes from too little oxygen reaching the heart, and dilating the coronary vessels increases blood and oxygen supply, while widening peripheral vessels lowers the heart's workload. These effects explain its use for high blood pressure and angina. The source notes that verapamil is not a first-line blood pressure drug under JNC-8 guidance, but it may be used when a patient also has atrial fibrillation or another arrhythmia.

The drug has a range of other roles described in the sources. It is used to prevent migraine and cluster headache, though the sources say the reason may involve effects on the body's circadian rhythm and on CGRP release. In cell biology it inhibits P-glycoprotein and other ABC transporter pumps, which helps researchers study drug resistance and cancer stem cells. A 2023 review of two randomised trials, covering a small group of people with recently diagnosed type 1 diabetes, found higher C-peptide levels after a year of treatment, a sign of better beta cell function. A separate rat study reported partial protection of the intestine from radiation injury, though the authors caution that their biomarker changes are not direct proof of functional benefit.

Side effects and limits matter. The most common is constipation, at about 7.3 percent, followed by dizziness, nausea, low blood pressure and headache. The drug is generally avoided in people with a weakened heart pumping function, very low blood pressure or certain heart rhythm conditions. It is absorbed well but has low bioavailability, around 10 to 35 percent, because of first-pass metabolism in the liver. Its effects are therefore shaped by how the body processes it, which is a useful lesson in why doses and patient histories are checked closely.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/health-verapamil.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…